SEARCH

SEARCH BY CITATION

References

  • Carr, J.M., Kruskall, M.S., Kaye, J.A. & Robinson, S.H. (1986) Efficacy of platelet transfusions in immune thrombocytopenia. American Journal of Medicine, 80, 10511054.
  • Cattaneo, M., Lecchi, A., Zighetti, M.L. & Lussana, F. (2007) Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. Haematologica, 92, 694697.
  • Fenger-Eriksen, C., Ingerslev, J. & Sorensen, B. (2009a) Fibrinogen concentrate – a potential universal hemostatic agent. Expert Opinion on Biological Therapy, 9, 13251333.
  • Fenger-Eriksen, C., Tonnesen, E., Ingerslev, J. & Sorensen, B. (2009b) Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids. Acta Anaesthesiologica Scandinavica, 53, 332338.
  • Ganter, M.T., Schmuck, S., Hamiel, C.R., Wischmeyer, P.E., Heule, D., Zollinger, A. & Hofer, C.K. (2008) Monitoring recombinant factor VIIa treatment: efficacy depends on high levels of fibrinogen in a model of severe dilutional coagulopathy. Journal of Cardiothoracic and Vascular Anesthesia, 22, 675680.
  • Hemker, H.C., Giesen, P., Al Dieri, R., Regnault, V., de Smedt, E., Wagenvoord, R., Lecompte, T. & Beguin, S. (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiology of Haemostasis and Thrombosis, 33, 415.
  • Keller-Stanislawski, B., Lohmann, A., Gunay, S., Heiden, M. & Funk, M.B. (2009) The German Haemovigilance System – reports of serious adverse transfusion reactions between 1997 and 2007. Transfusion Medicine, 19, 340349.
  • Kjalke, M., Ezban, M., Monroe, D.M., Hoffman, M., Roberts, H.R. & Hedner, U. (2001) High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system. British Journal of Haematology, 114, 114120.
  • Kristensen, J., Killander, A., Hippe, E., Helleberg, C., Ellegard, J., Holm, M., Kutti, J., Mellqvist, U.H., Johansson, J.E., Glazer, S. & Hedner, U. (1996) Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis, 26 Suppl 1, 159164.
  • Lacey, J.V. & Penner, J.A. (1977) Management of idiopathic thrombocytopenic purpura in the adult. Seminars in Thrombosis and Hemostasis, 3, 160174.
  • Lang, T., Johanning, K., Metzler, H., Piepenbrock, S., Solomon, C., Rahe-Meyer, N. & Tanaka, K.A. (2009) The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesthesia and Analgesia, 108, 751758.
  • Larsen, O.H., Ingerslev, J. & Sorensen, B. (2007) Whole blood laboratory model of thrombocytopenia for use in evaluation of hemostatic interventions. Annals of Hematology, 86, 217221.
  • Larsen, O.H., Clausen, N., Persson, E., Ezban, M., Ingerslev, J. & Sorensen, B. (2009) Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue. British Journal of Haematology, 144, 99106.
  • Larsen, O.H., Ezban, M., Persson, E., Ingerslev, J. & Sorensen, B. (2010) Artificial contact pathway activation masks the haemostatic potential of rFVIIa and NN1731 in thrombocytopenic whole blood. British Journal of Haematology, 150, 124127.
  • Larsen, O.H., Fenger-Eriksen, C., Christiansen, K., Ingerslev, J. & Sorensen, B. (2011) Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents. Anesthesiology, 115, 294302.
  • Lauritzen, B., Tranholm, M. & Ezban, M. (2009) rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats. Journal of Thrombosis and Haemostasis, 7, 651657.
  • Lisman, T., Adelmeijer, J., Cauwenberghs, S., Van Pampus, E.C., Heemskerk, J.W. & De Groot, P.G. (2005) Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count. Journal of Thrombosis and Haemostasis, 3, 742751.
  • Logan, A.C. & Goodnough, L.T. (2010) Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting. Hematology American Society of Hematology Education Program Book, 2010, 153159.
  • Luddington, R. & Baglin, T. (2004) Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. Journal of Thrombosis and Haemostasis, 2, 19541959.
  • Mann, K.G., Whelihan, M.F., Butenas, S. & Orfeo, T. (2007) Citrate anticoagulation and the dynamics of thrombin generation. Journal of Thrombosis and Haemostasis, 5, 20552061.
  • Misgav, M., Shenkman, B., Budnik, I., Einav, Y. & Martinowitz, U. (2011) Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia. Anesthesia and Analgesia, 112, 10341040.
  • Monroe, D.M., Hoffman, M., Oliver, J.A. & Roberts, H.R. (1997) Platelet activity of high-dose factor VIIa is independent of tissue factor. British Journal of Haematology, 99, 542547.
  • Mosesson, M.W. (2005) Fibrinogen and fibrin structure and functions. Journal of Thrombosis and Haemostasis, 3, 18941904.
  • Norgaard, M., Jensen, A.O., Engebjerg, M.C., Farkas, D.K., Thomsen, R.W., Cha, S., Zhao, S. & Sorensen, H.T. (2011) Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. Blood, 117, 35143520.
  • Page, L.K., Psaila, B., Provan, D., Michael, H.J., Jenkins, J.M., Elish, A.S., Lesser, M.L. & Bussel, J.B. (2007) The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. British Journal of Haematology, 138, 245248.
  • Pihusch, M., Bacigalupo, A., Szer, J., von Depka, P.M., Gaspar-Blaudschun, B., Hyveled, L. & Brenner, B. (2005) Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation. Journal of Thrombosis and Haemostasis, 3, 19351944.
  • Provan, D., Stasi, R., Newland, A.C., Blanchette, V.S., Bolton-Maggs, P., Bussel, J.B., Chong, B.H., Cines, D.B., Gernsheimer, T.B., Godeau, B., Grainger, J., Greer, I., Hunt, B.J., Imbach, P.A., Lyons, G., McMillan, R., Rodeghiero, F., Sanz, M.A., Tarantino, M., Watson, S., Young, J. & Kuter, D.J. (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 115, 168186.
  • Rand, M.D., Lock, J.B., van't Veer, C., Gaffney, D.P. & Mann, K.G. (1996) Blood clotting in minimally altered whole blood. Blood, 88, 34323445.
  • Salama, A., Kiesewetter, H., Kalus, U., Movassaghi, K. & Meyer, O. (2008) Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia. Thrombosis and Haemostasis, 100, 762765.
  • Salama, A., Rieke, M., Kiesewetter, H. & von Depka, M. (2009) Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature. Annals of Hematology, 88, 1115.
  • Sorensen, B., Johansen, P., Christiansen, K., Woelke, M. & Ingerslev, J. (2003) Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. Journal of Thrombosis and Haemostasis, 1, 551558.
  • Sorensen, B., Asvaldsdottir, H.S., Gudmundsdottir, B.R. & Onundarson, P.T. (2009) The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery. Thrombosis Research, 124, 695700.
  • Spahr, J.E. & Rodgers, G.M. (2008) Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients. American Journal of Hematology, 83, 122125.
  • Spiess, B.D., Royston, D., Levy, J.H., Fitch, J., Dietrich, W., Body, S., Murkin, J. & Nadel, A. (2004) Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion, 44, 11431148.
  • Tanaka, K.A., Taketomi, T., Szlam, F., Calatzis, A. & Levy, J.H. (2008) Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P). Anesthesia and Analgesia, 106, 732738.
  • Velik-Salchner, C., Schnurer, C., Fries, D., Mussigang, P.R., Moser, P.L., Streif, W., Kolbitsch, C. & Lorenz, I.H. (2006) Normal values for thrombelastography (ROTEM) and selected coagulation parameters in porcine blood. Thrombosis Research, 117, 597602.
  • Velik-Salchner, C., Haas, T., Innerhofer, P., Streif, W., Nussbaumer, W., Klingler, A., Klima, G., Martinowitz, U. & Fries, D. (2007) The effect of fibrinogen concentrate on thrombocytopenia. Journal of Thrombosis and Haemostasis, 5, 10191025.